Literature DB >> 7836760

Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.

R L Hunter1, M R Kidd, M R Olsen, P S Patterson, A A Lal.   

Abstract

We previously reported that protection of mice from nonlethal Plasmodium yoelii malaria by immunization with whole killed blood-stage parasites was dependent on the adjuvant and that adjuvants influenced both the specificity and isotype of Ab. Additional studies with the most effective formulations were undertaken to better define the protective responses and 100% protection from lethal P. yoelii malaria was produced by three immunizations with Ag in copolymer P1004 and detoxified RaLPS as adjuvants and 83% protection was induced by a single immunization. The protection lasted for 9 mo and was associated with an anamnestic rise in Ab titer of the IgG2a isotype during the challenge infection. Passive immunization with Ab from animals that had been immunized and challenged transferred sterile immunity. Splenectomy reduced, but did not abolish, protection. These data suggest that the effective Ab is directed against labile epitopes on the surface of blood-stage parasites. The vaccines primed animals for production of such Ab, but its synthesis was efficiently induced only by challenge with live organisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7836760

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant.

Authors:  C Yang; W E Collins; J S Sullivan; D C Kaslow; L Xiao; A A Lal
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens.

Authors:  J M Burns; P D Dunn; D M Russo
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria.

Authors:  V M Jennings; A A Lal; R L Hunter
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

4.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

5.  Immunomodulator effect of picroliv and its potential in treatment against resistant Plasmodium yoelii (MDR) infection in mice.

Authors:  Varun Dwivedi; Arif Khan; Azevedo Vasco; Nishat Fatima; Vishal Kumar Soni; Anil Dangi; Shailja Misra-Bhattacharya; Mohammad Owais
Journal:  Pharm Res       Date:  2008-06-13       Impact factor: 4.200

6.  Memory CD8 T-cell compartment grows in size with immunological experience.

Authors:  Vaiva Vezys; Andrew Yates; Kerry A Casey; Gibson Lanier; Rafi Ahmed; Rustom Antia; David Masopust
Journal:  Nature       Date:  2008-11-12       Impact factor: 49.962

7.  Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant.

Authors:  J B De Souza; I T Ling; S A Ogun; A A Holder; J H Playfair
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.